FERRARESE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 41.225
EU - Europa 21.288
AS - Asia 7.657
SA - Sud America 115
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 27
AF - Africa 26
Totale 70.400
Nazione #
US - Stati Uniti d'America 40.475
IT - Italia 5.329
DE - Germania 3.256
CN - Cina 3.102
SE - Svezia 3.001
IE - Irlanda 2.417
SG - Singapore 2.415
RU - Federazione Russa 1.931
UA - Ucraina 1.901
GB - Regno Unito 1.156
HK - Hong Kong 886
CA - Canada 721
FI - Finlandia 625
AT - Austria 428
FR - Francia 353
VN - Vietnam 353
IN - India 341
TR - Turchia 217
DK - Danimarca 192
BE - Belgio 178
NL - Olanda 153
PL - Polonia 105
IR - Iran 85
BR - Brasile 80
ID - Indonesia 77
JP - Giappone 68
CZ - Repubblica Ceca 61
EU - Europa 55
ES - Italia 39
KR - Corea 36
CH - Svizzera 31
AU - Australia 25
MX - Messico 21
GR - Grecia 18
RO - Romania 18
CL - Cile 17
PT - Portogallo 15
NO - Norvegia 13
LT - Lituania 12
BG - Bulgaria 11
MY - Malesia 9
PH - Filippine 9
AL - Albania 8
EG - Egitto 8
TW - Taiwan 8
PA - Panama 7
A2 - ???statistics.table.value.countryCode.A2??? 6
TH - Thailandia 6
BD - Bangladesh 5
HU - Ungheria 5
MT - Malta 5
MU - Mauritius 5
PE - Perù 5
SA - Arabia Saudita 5
IL - Israele 4
LV - Lettonia 4
MD - Moldavia 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
IQ - Iraq 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MN - Mongolia 3
SC - Seychelles 3
ZA - Sudafrica 3
BO - Bolivia 2
CI - Costa d'Avorio 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
SM - San Marino 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
EC - Ecuador 1
GA - Gabon 1
KH - Cambogia 1
MA - Marocco 1
MC - Monaco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PS - Palestinian Territory 1
TL - Timor Orientale 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 70.400
Città #
Ann Arbor 8.919
Woodbridge 4.248
Chandler 3.097
Fairfield 2.816
Houston 2.657
Dublin 2.330
Jacksonville 2.162
Frankfurt am Main 2.103
Ashburn 1.933
Singapore 1.918
Wilmington 1.826
Dearborn 1.368
Milan 1.205
Seattle 1.168
New York 1.128
Cambridge 992
Santa Clara 982
Princeton 972
Hong Kong 864
Nanjing 555
Shanghai 491
Vienna 420
Lachine 375
Lawrence 367
Beijing 359
Boardman 339
Altamura 324
Dong Ket 208
Helsinki 188
San Diego 185
Nanchang 184
Hangzhou 175
Shenyang 172
Brussels 169
Andover 156
Rome 154
Guangzhou 153
Fremont 139
Toronto 129
Hebei 124
Mountain View 123
Falls Church 118
Ottawa 110
Tianjin 110
Changsha 100
Munich 95
Jinan 92
London 92
Pune 83
Jiaxing 81
Los Angeles 81
Lissone 75
Kraków 74
Grafing 72
Dallas 70
Jakarta 70
Zhengzhou 70
Ningbo 66
Huizen 61
Norwalk 61
Detroit 57
Turin 55
Monza 54
Lappeenranta 48
Brno 47
Edmonton 46
Kunming 46
Chicago 45
Pisa 44
Redmond 42
Carate Brianza 41
San Mateo 40
Nürnberg 38
Auburn Hills 37
Hefei 37
Leawood 35
Bologna 34
Florence 34
University Park 34
Lecco 32
Torino 32
Philadelphia 31
Washington 31
Naples 29
Taizhou 29
Como 26
Kocaeli 25
Monmouth Junction 25
Catania 22
São Paulo 22
Amsterdam 21
Bergamo 21
Desio 20
Kilburn 20
Rozzano 20
Tehran 20
Fuzhou 19
Napoli 19
Palermo 19
Segrate 19
Totale 51.074
Nome #
The hand pronation phenomenon: a franco-german tale 1.548
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 427
Assessing early to late stage dementia: the TSI and BANS-S scales in the nursing-home 396
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 395
Using global team science to identify genetic parkinson's disease worldwide 380
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 371
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 362
Cognitive assessment of severe dementia: The test for severe impairment (TSI) 338
Substrate-induced modulation of glutamate uptake in human platelets 334
Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake 325
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 311
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 309
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 306
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 305
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 303
Malattie del Sistema Nervoso 300
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 295
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 293
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 292
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 284
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 283
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 281
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 279
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 279
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 272
Physical anhedonia in Parkinson's disease 270
Incidence and predictors of acute symptomatic seizures after stroke 265
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 260
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 256
The role of clinical and neuroimaging features in the diagnosis of CADASIL 253
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 252
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 246
Generation and validation of algorithms to identify subjects with dementia using administrative data 245
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 241
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 240
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 240
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 239
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 237
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 236
Reduced platelet glutamate uptake in Parkinson's disease 235
Adherence to recommendations and clinical outcomes of patients hospitalized for stroke: the role of the admission ward—a real-life investigation from Italy 234
The one-carbon metabolism in anorexia nervosa of the restrictive type 232
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 229
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 228
Atypical parkinsonism and intrathecal anti-glutamic acid decarboxylase antibodies - An unusual association: A case report 225
Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease 224
Mutual Information Optimization for Mass Spectra Data Alignment 224
Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise 222
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 221
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 220
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 218
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 217
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 216
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 215
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 214
Guillain-Barré syndrome related to COVID-19 infection 214
Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors 213
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 208
Malattie del Sistema Nervoso 205
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 204
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 203
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 202
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 202
Degenerazione Cortico-Basale: cos’è “corticale” e cosa “basale”? 201
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 199
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 197
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 197
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 197
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 197
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 196
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 195
High-dose atorvastatin after stroke or transient ischemic attack 194
Validation of the Italian version of the ALS cognitive-behavioral screen (ALS-CBS): preliminary results 194
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 191
Micrornas in als: from molecular mechanisms to clinical relevance 190
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 188
Nonfibrillar Abeta 1-42 inhibits glutamate uptake and phosphorylates p38 in human fibroblasts 188
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 187
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 186
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 186
Primary Whipple disease of the Central Nervous System presenting with rhombencephalitis 185
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 184
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 183
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 183
Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients 182
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 182
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 182
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 181
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 180
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 180
Posterior reversible encephalopathy syndrome (PRES) associated with acute pancreatitis 179
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 178
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 177
On scrapie interference and artificial prions 177
Large-scale assessment of polyglutamine repeat expansions in Parkinson disease 177
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 176
The Neuropsychiatric Profile of Posterior Cortical Atrophy 175
Behavioural anomalies in neurodegenerative diseases: role of the immune response 175
A Case of Reversible Dementia Due to a Strictly Fruitarian Diet If an Apple a Day Keeps the Doctor Away, a Fruitarian Diet Throws Your Mind Away 175
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 174
Totale 24.841
Categoria #
all - tutte 238.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.737 0 0 0 0 1.045 1.377 1.723 755 1.046 726 831 234
2020/20219.813 692 459 1.051 1.051 739 702 967 763 883 1.049 561 896
2021/20226.873 636 684 879 606 489 559 290 325 356 419 558 1.072
2022/202311.873 1.306 3.445 1.029 1.223 814 1.757 162 641 834 113 329 220
2023/20248.675 308 301 439 446 1.080 2.139 1.566 364 543 205 246 1.038
2024/20256.222 1.139 2.266 1.206 851 760 0 0 0 0 0 0 0
Totale 73.180